We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Shire, Santaris Extend Alliance For Rare Disease Drug Development
Shire, Santaris Extend Alliance For Rare Disease Drug Development
August 30, 2013
Shire and Santaris have extended an agreement to develop new therapies for rare genetic disorders, rejuvenating efforts to thrust their partnered compounds into the pre-clinical stage.